-+ 0.00%
-+ 0.00%
-+ 0.00%

VANDA PHARMACEUTICALS INC - JAPAN GRANTS ORPHAN DRUG DESIGNATION TO IMSIDOLIMAB FOR GENERALIZED PUSTULAR PSORIASIS

Reuters·05/27/2026 11:06:02

Please log in to view news